IL6 and COVID-19: A hallmark of early COVID-19 is an increase in pro-inflammatory cytokines, especially IL-6 and TNFα, as well as IL-1 β, IL-8, GM-CSF, and the type 2 inflammatory cytokine IL-13 [1,25,26].